This benchmark evaluates a model's ability to identify and classify clinical evidence spans within randomized controlled trial (RCT) documents. Specifically, it probes whether a given evidence span supports a significantly decreased, no significant difference, or significantly increased outcome relative to a clinical intervention. Use when the user wants to benchmark on Evidence Inference, or asks about evaluating this task. Reports macro-averaged F1.
Installs into .claude/skills of the current project.
Are you the author of Evidence Inference Eval?
Add the live security badge to your README. It updates with every re-scan.
[](https://www.skillsdirectory.com/skills/qhjqhj00-evidence-inference-eval)
---
name: evidence-inference-eval
description: This benchmark evaluates a model's ability to identify and classify clinical evidence spans within randomized controlled trial (RCT) documents. Specifically, it probes whether a given evidence span supports a significantly decreased, no significant difference, or significantly increased outcome relative to a clinical intervention. Use when the user wants to benchmark on Evidence Inference, or asks about evaluating this task. Reports macro-averaged F1.
metadata:
skill_kind: dataset_eval
source_arxiv: 2005.04177
bibtex_key: [REDACTED]
confidence: high
---
# evidence-inference-eval
> Evidence Inference 2.0: More Data, Better Models — DeYoung et al. (2020) (arXiv:2005.04177, 2020)
## What this evaluates
This benchmark evaluates a model's ability to identify and classify clinical evidence spans within randomized controlled trial (RCT) documents. Specifically, it probes whether a given evidence span supports a significantly decreased, no significant difference, or significantly increased outcome relative to a clinical intervention.
## Datasets
- **Evidence Inference** — total ?; splits: test (-1)
## Metrics
- `macro-averaged F1` **(primary)** — range: [0, 1]
- Macro-averaged F1 score computed across three classes: significantly decreased, no significant difference, and significantly increased. Calculated as the unweighted mean of per-class F1 scores.
## Input / output format
**Input**: A clinical intervention/comparison/outcome (ICO) prompt and a candidate evidence span or sentence extracted from a full RCT document or abstract.
**Output**: One of three classification labels: 'significantly decreased', 'no significant difference', or 'significantly increased'.
## Scoring recipe
```python
def compute_macro_f1(predictions, gold):
classes = ['sig_decreased', 'sig_no_diff', 'sig_increased']
f1_scores = []
for cls in classes:
tp = sum(1 for p, g in zip(predictions, gold) if p == cls and g == cls)
fp = sum(1 for p, g in zip(predictions, gold) if p == cls and g != cls)
fn = sum(1 for p, g in zip(predictions, gold) if p != cls and g == cls)
prec = tp / (tp + fp) if (tp + fp) > 0 else 0
rec = tp / (tp + fn) if (tp + fn) > 0 else 0
f1 = 2 * prec * rec / (prec + rec) if (prec + rec) > 0 else 0
f1_scores.append(f1)
return sum(f1_scores) / len(f1_scores)
```
## Common pitfalls
- Models must be conditioned on the ICO prompt; unconditioned models drop ~27 F1 points.
- The evaluation uses a two-stage pipeline (evidence identification followed by classification); end-to-end scores are lower than oracle evidence baselines by ~0.08 F1.
- Abstract-only subsets yield nearly identical performance to full-document subsets, but oracle abstract models underperform oracle full-document models due to differences in reporting language.
## Evidence (verbatim from paper)
> Our main results are reported in Table 1. We make a few key observations. First, the gains over the prior state-of-the-art model — which was not BERT based — are substantial: 20+ absolute points in F-score, even beyond what one might expect to see shifting to large pre-trained models. To verify the impact of architecture changes, we experiment with randomly initialized and fine-tuned BERTs. We find that these perform worse than the original models in all instances and elide more detailed results. Second, conditioning on the ICO prompt is key; failing to do so results in substantial performance drops. Finally, we seem to have reached a plateau in terms of the performance of the BERT pipeline model; adding the newly collected training data does not budge performance (evaluated on the augmented test set). This suggests that to realize stronger performance here, we perhaps need a less naive architecture that better models the domain.
## Citation
```bibtex
@misc{deyoung2020evidenceinference2,
title={Evidence Inference 2.0: More Data, Better Models},
author={DeYoung et al. (2020)},
year={2020},
note={arXiv:2005.04177}
}
```
- arXiv: 2005.04177